Form 4 for STOK Stoke Therapeutics, Inc.
Accepted 2021-11-03 00:00:00 ET · period of report 2021-11-01 · accession 0001209191-21-062772 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-03 | 2021-11-01+ | STOK | Nash Huw M. | COO, CBO | S - Sale+OE | $24.03 | -5,700 | 1,610 | -78% | -$137.0K |
| DM | 2021-11-03 | 2021-11-01+ | STOK | Nash Huw M. | COO, CBO | M - OptEx | $2.19 | +5,700 | 3,800 | New | +$12.5K |
| DM | 2021-11-03 | 2021-11-01+ | STOK | Nash Huw M. | COO, CBO | M - OptEx | $0.00 | -5,700 | 98.2K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-03 | S | D | 1,900 | $25.00 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-03 | M | A | 1,900 | $2.19 | 1,900 | D | — | — | |
| 3 | Common | Common Stock | 2021-11-01 | S | D | 1,610 | $23.72 | 0 | D | — | — | (F3) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.68 to $23.76 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2021-11-01 | S | D | 2,190 | $23.41 | 1,610 | D | — | — | (F2) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.67 to $23.66 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2021-11-01 | M | A | 3,800 | $2.19 | 3,800 | D | — | — | |
| 6 | Derivative | Employee Stock Option (Right to Buy) | 2021-11-03 | M | D | 1,900 | $0.00 | 96,322 | D | $2.19 · — to 2028-12-12 | 1,900 Common Stock | (F4) The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date. |
| 7 | Derivative | Employee Stock Option (Right to Buy) | 2021-11-01 | M | D | 3,800 | $0.00 | 98,222 | D | $2.19 · — to 2028-12-12 | 3,800 Common Stock | (F4) The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date. |